In conclusion, this study identified statistically significant associations for a genetic variant in SULT1E1 with MTX plasma levels and three genetic variants in CYP2B6 and CYP4F8 with thrombocyte counts after HD-MTX infusion in osteosarcoma patients. Here, CYP2B6 is linked to osteosarcoma.